Prevention of stricture development after corrosive esophageal burn with a modified esophageal stent in dogs  by Zhou, Jing-Hai et al.
G
T
S
General Thoracic Surgery Zhou et alPrevention of stricture development after corrosive esophageal burn
with a modified esophageal stent in dogs
Jing-Hai Zhou, MD, Yao-Guang Jiang, MD, Ru-Wen Wang, MD, Shi-Zhi Fan, MD, Tai-Qian Gong, PhD, Qun-You Tan, PhD,
Zheng Ma, PhD, Yun-Ping Zhao, PhD, and Bo Deng, MD
Objective: We sought to test the feasibility and technical ease of a newly designed nitinol–based modified esoph-
ageal stent and its effects on preventing postcaustic stricture in mongrel dogs and to try to explain the result at the
molecular level.
Methods: Twenty-four dogs were included in this controlled study. Stenosis index (wall thickness/intraluminal
diameter), pathologic features, hydroxyproline quantities, esophageal compliance, and biomechanics were com-
pared between the injured but unstented and stented dogs. Transforming growth factor b1, Sma/Mad (Smad)3,
and Smad7 mRNA expression and protein levels in esophageal tissue were detected by means of reverse tran-
scriptase–polymerase chain reaction and Western blotting, respectively.
Results: The modified esophageal stent was able to be placed and retrieved successfully and conveniently and
was not only intact but there was also no macroscopic esophageal mucosal injury after the stent removal 4 months
later. In comparison with the injured but unstented group, esophageal compliance, biomechanics, and the stenosis
index were significantly better in the stented group. Histopathologic study revealed that collagen bundles were
thinner and its orientation tended toward a regular and parallel pattern. Transforming growth factor b1 and
Smad3 mRNA expression and protein levels increased and Smad7 mRNA expression and protein levels de-
creased significantly in esophageal tissue in the stented group. These variables showed no statistically significant
difference 2 months after stent removal.
Conclusions: The modified esophageal stent might be a promising stent in preventing stricture formation after
corrosive esophageal burns clinically.Supplemental material is available online.
Management of esophageal stricture, which has been one of
the serious late complications after corrosive esophageal
burns, is tricky and expensive. Therefore prevention of stric-
ture formation is indispensable and cost-effective at the early
phase after caustic agent ingestion.1-3 Among the currently
preventive modalities, including neutralization of caustic
agent, corticosteroids, antibiotics, and dilation, intraluminal
esophageal stenting is one of the most effective therapies.4
However, nearly all of the stents used to prevent stricture
formation after corrosive esophageal burns are constructed
of medical silicone tubing and have the drawback of being
readily obstructive, and the patient who has undergone
esophageal intraluminal stenting can only eat liquid or semi-
liquid food.5,6
From the Department of Thoracic Surgery, Daping Hospital, Third Military Medical
University, Chongqing, China.
Received for publication Aug 18, 2007; revisions received Dec 8, 2007; accepted for
publication Feb 12, 2008.
Address for reprints: Yao-Guang Jiang, MD, Department of Thoracic Surgery, Daping
Hospital, Third Military Medical University, Chongqing 400042, China (E-mail:
zhzhlu1993@yahoo.com.cn).
J Thorac Cardiovasc Surg 2008;136:1336-42
0022-5223/$34.00
Copyright  2008 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2008.02.0861336 The Journal of Thoracic and Cardiovascular SExpandable metallic stents have become popular for the
treatment of malignant esophageal strictures in recent years.
Although they are undoubtedly of great value in the pallia-
tion of nonoperable advanced esophageal cancers, there is
concern over their use for the treatment of benign diseases.
This is because stent removal is challengeable and might
be hazardous because of the intense fibrotic reaction induced
by the stent.7,8 Although some authors9,10 reported that some
metal stents were extracted without surgical intervention,
they were only able to remove one that had been placed
less than 1 month prior, even within 1 week. However, it
has been known that esophageal stents should be kept in
place for several months if they prevent postcaustic stricture
formation effectively.3
We modified the metallic stents (modified esophageal
stent [MES]) based on the covered expandable nitinol stent
available (Beijing Grikin Advanced Materials Co Ltd) so
that the MES could be removed 4 months after placement.
The purpose of this study was to test the feasibility and tech-
nical ease of MES and its effects on preventing postcaustic
esophageal stricture in mongrel dogs. We also attempt to
provide some insight as to the pathophysiology of the find-
ings noted with the stent and extend our observations in an
effort to explain such findings at the molecular level.
MATERIALS AND METHODS
Five knowledgeable professors had been invited to review the study, in-
cluding how to treat the animals humanely, before the experiment started.urgery c November 2008
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MES ¼ modified esophageal stent
PCR ¼ polymerase chain reaction
TGF-b1 ¼ transforming growth factor b1
After ethics committee approval of the protocol, a preliminary experiment
had been conducted to standardize the experimental model and the proce-
dure for MES placement and removal. All the experimental procedures
were performed in light of the ‘‘Management details on animals in medical
experiments’’ of the National Health Ministry (1998).
Animal Model
The dogs were housed in indoor runs and fed at our experimental animal
center and were cared for by an experienced animal handler under the su-
pervision of an administrator in animal specialty. After overnight fasting,
each dog was weighed and anesthetized with intramuscular injection of Su-
mianxin II (0.2 mL/kg; Changchun Agricultural Pastoral University),
a combination of xylazole, ethylenediamine tetra-acetic acid, dihydroetor-
phine hydrochloride, and haloperidol. The dogs were closely monitored,
and a heating pad was used to maintain body temperature during the pro-
cedure. The length from the cuspid to the thoracic esophagus was mea-
sured, and a guide wire was placed during endoscopic guidance. Two
16F Foley catheters sheathed the guide wire and were inserted into the tho-
racic esophagus in tandem. The distance between the catheters was adjusted
to 10 cm away after the guide wire withdrawal. Ten milliliters of 10%
NaOH solution was infused through the proximal catheter and left in place
for 1 minute. Then the solution was aspirated with an injector, and 20 mL of
saline was used to lavage the injured area 3 times. Rigid endoscopy was
performed to confirm the degree of injury 24 hours later. Dogs were al-
lowed to eat liquid 3 days after the injury. Any medication, including ste-
roids, antibiotics, and proton pump inhibitors, that might have an influence
on the esophageal stricture formation were not administered in the wake of
caustic injury, but fluid was transfused until the dogs had a normal intake of
fluid food after the procedure. Antalgics were administered once daily for
the first 3 postoperative days. The dogs were examined twice daily for
the first 7 postoperative days and once daily thereafter. The animals were
observed for signs of pain, distress, fever, and melena. All the animals
were weighed every month, and nutrition was maintained intravenously
if they lost more than 30% of initial weight. The animal’s digestive man-
ifestations and mortalities were noted during the observation period.
MES
Design. Our MES had the following characteristics: (1) the MES was 16
cm in length and 2 cm in diameter; (2) silicone coating of 1 cm beyond the
upper metal cage was affixed to the inside and outside of the stent; (3) a piece
of nitinol string of 0.5 mm in diameter and 50 cm in length transfixed the
upper metal circumference of MES; and (4) plastic valves were attached
to the lower end of the MES (Figure 1).
MES placement. The MES was inserted into the canine esophagus 2
weeks after corrosive injury by using a delivery system during endoscopic
guidance. After the stent was deployed, the delivery system and the tip of
the MES string were brought out of the oral cavity. Esophagoscopy was
again performed to verify the ideal position of the MES, which was located
2 to 4 cm beyond the proximal and distal borderline of the esophageal le-
sion. Finally, the proximal part of the nitinol string was sheathed in a 10F
catheter and penetrated out of the pharynx and subsequently secured on
the neck.
MES removal. The MES was removed after 4 months. A 16F Foley
catheter was placed at the proximal end of the MES during endoscopic guid-
ance, and 100 mL of icy saline was administered while the dog was kept inThe Journal of Thoracic and Ca semi-Fowler’s position (with head and thorax at 45 elevation). The MES
string was replaced into the pharynx and brought out of the oral cavity. A
rigid esophagoscope was passed over the MES string before it was inserted
into the esophagus. The MES string was continuously pulled while the en-
doscope was continuously advanced until the whole MES entered it. Then
the endoscope was moved backward gradually, and the MES was removed
simultaneously. The MES was detected carefully, if it was still intact. Fi-
nally, endoscopy was again performed to observe whether the esophagus
had stricture, ulcer, bleeding, or perforation.
Experimental Groups
Four randomized groups, each of 6 mongrel dogs, were included in this
study. Group A (n ¼ 6), the control animals, were uninjured and untreated.
Group B (n ¼ 6) had untreated esophageal burns and were humanely killed
with 190 mg/kg pentobarbital sodium by means of intravenous injection 4.5
months after the injury if they still survived. The other dogs, which had been
subjected to corrosive esophageal burns and treated with MESs 2 weeks af-
ter injury and had the MESs removed 4 months later, were divided into 2
groups according to the observation period after MES withdrawal. The
dogs in group C (n ¼ 6) were killed immediately after the MES removal,
FIGURE 1. Schematic diagram of a modified esophageal stent. A long
piece of nitinol string transfixed the upper metal circumference of the mod-
ified esophageal stent. Silicone membrane exceeding the upper metal cage
by 1 cm was affixed to the inside and outside of the stent. Plastic valves were
attached to the lower end of the modified esophageal stent.ardiovascular Surgery c Volume 136, Number 5 1337
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observation after the MES withdrawal.
Pathologic Study and Sample Storage
Animals dying in the late phase or being killed at the end of the experi-
ment were weighed before autopsy. After the esophagus was harvested, the
distal end of the injured area was ligated, and its proximal end was con-
nected to a 3-way stopcock, which one way linked with a barometer and
the third way attached to a 50-mL injecting syringe to detect esophageal
compliance, which was expressed by the ratio of esophageal pressure to
the injected water (in centimeters of H2O/ per milliliter). Then the injured
esophagus was opened longitudinally, maximum esophageal wall thickness
and minimum intraluminal diameter were assessed, and stenosis index (wall
thickness/intraluminal diameter) was calculated subsequently. The maxi-
mum esophageal wall was selected for histologic sectioning. A part of
each specimen was fixed in 4% paraformaldehyde and dehydrated, cleared,
infiltrated, and embedded in paraffin. Four slides, each 4 to 6 mm in thick-
ness, were stained with hematoxylin and eosin. The other fraction of tissues
in groups B and D were fixed in 2% glutaraldehyde for ultrastructure study.
The remaining tissues were frozen with liquid nitrogen and kept at70C to
determine hydroxyproline quantities and transforming growth factor b1
(TGF-b1), Smad3, and Smad7 mRNA expression and protein levels and
to detect esophageal biomechanics.
Hydroxyproline Quantity Assay
Hydroxyproline content of the esophageal tissue was determined accord-
ing to the modified methods described by Reddy and Enwemeka.11 Fifty to
eighty milligrams of esophageal tissues that had been thawed were hydro-
lyzed, oxidized, and vortexed. Then the optical densities of color samples
were read with a spectrophotometer at 550 nm. Hydroxyproline concentra-
tions were calculated by means of a standard curve with standard solutions.
The hydroxyproline content was expressed as micrograms per milligram of
tissue.
Detection of Esophageal Biomechanics
An Instron tensile strength tester controlled by a computer was applied to
investigate biomechanics of the samples. The esophageal tissues were fas-
tened between the 2 grips, which were 5 cm away from each other, in the
machine. The specimen was fixed relative to the lower clips and then sub-
jected to a tensile load as the upper clips moved upward. Preliminary load-
ing was performed 3 times so that the entire sample experienced
a homogenous tension while testing. Fifteen millimeters per minute at ve-
locity, 0.01 MegaPascal (MP) in fixed load, and 30% of extension of the
samples were set up, and esophageal biomechanics, including maximum
load, elastic module, yield strength, intensive strengths, rupture intensity,
applied strength, stretch rate at rupture, and stretch rate at definite force,
were demonstrated on the computer while the specimen was extending.
Reverse transcriptase–polymerase chain reaction
Reverse transcriptase–polymerase chain reaction (PCR) was used to analyze
TGF-b1, Smad3, and Smad7 mRNA expression in esophageal tissue in dogs.
Total RNA was extracted from each of the esophageal tissues with Tripure
reagent (Roche), according to the manufacturer’s instructions. For amplification
of the desired cDNA, the following gene-specific primers were used,12-14
and b-actin was measured as an internal control: TGF-b1 (151 bp),
upstream 50-CAAAGACTTTTCCCCAGACCTC-30 and downstream 50-
GGGTGGTCTTGAATAGGGGATC-30; Smad3 (188 bp), upstream 50-CCA
GAGAGTAGAGACACCAGTTC-30 and downstream 50–CTCCATCTT
CACTCAGGTAGCC-30; Smad7 (179 bp), upstream 50-GATGGATTTTCT
CAAACCAACTGC-30 and downstream 50-TCCCCACTCTCGTCTTCTCC-
30; and b-actin (309 bp), upstream 50-TCCCTCAAGATTGTCAGCAA-30
and downstream 50–AGATCCACAACGGATACATT-30. Nested PCR re-
actions were all assembled in 25 mL containing cDNA, MgCl2, primers,1338 The Journal of Thoracic and Cardiovascular Suand Taq DNA polymerase. Samples were amplified for 27 cycles in a gradient
PCR machine (Eppendorf) at denaturation (95C for 1 minute for TGF-b1
and Smad3 or 94C for 1 minute for Smad7), annealing (58C for 55 seconds
for TGF-b1 or 56C for 55 seconds for Smad3 and Smad7), and extension
(72C for 40 seconds for TGF-b1 or 72C for 1 minute for Smad3 and
Smad7). The PCR products were electrophoresed on 1.5% agarose gels,
stained with ethidium bromide, and observed with UV transillumination
(Beckman). Intensity of the scanned image was determined with image
analysis software (UVP) and was expressed by the number of white pixel areas.
Results were calculated as a ratio of intensity of the specimen to the control
gene b-actin.
Western Blotting
Western blotting was used for the measurement of TGF-b1, Smad3, and
Smad7 protein levels in esophageal tissues in experimental animals. Protein
extract was separated by using 10% sodium dodecylsulfate–polyacryl-
amide gel electrophoresis and transferred to polyvinylidene difluoride mem-
branes. After being blocked with 6% skim milk, the membranes were
probed with rabbit anti-TGF-b1, goat anti-Smad3, or goat anti-Smad7 anti-
bodies (Santa Cruz Biotechnology) at a dilution of 1:2000 for 1 hour, fol-
lowed by a 1-hour incubation with secondary anti-rabbit or anti-goat
horseradish peroxidase–conjugated antibody (1:5000). Then a chemilumi-
nescence signal was produced (DuPont) and captured on x-ray film. The re-
sults were expressed as a ratio of specimen Optical Density (OD) to samples
in group A, which was as used the control arbitrarily.
Statistical Analysis
Data are expressed as medians with interquartile ranges. Statistical anal-
ysis was performed by using 1-way analysis of variance with SPSS 10.0 for
windows (SPSS, Inc).
RESULTS
Clinical Behavior
Second- or third-degree injury was confirmed, and the
length of the diseased esophagus was similar among groups
B, C, and D by means of esophagoscopy, which was per-
formed 24 hours after lye contact. One dog that died of
esophageal perforation and acute mediastinitis within 24
hours after injury was excluded in group B. The remaining
dogs in this group had dysphagia followed by regurgitation
and cachexia since 3 weeks after the burns. Three animals
died of malnutrition during the second month after injury,
and the other animal died 1 month later, even when nutrition
was maintained intravenously. Only 1 dog with untreated
burns survived at the end of the observation period. As for
the dogs being treated with the MES in the wake of lye in-
gestion, animals had anorexia in the first week after stent
placement but had ravenous appetites 2 weeks later. All
dogs had been able to eat a soft diet 3 weeks after MES
use. The MES was removed successfully and conveniently
4 months after placement. All the extracted MESs were in-
tact, and there were no blood blots or esophageal tissues
on the outside of the MESs in groups C and D (Figure E1).
Weight
All 23 dogs were weighed after death or before being
killed. The eventual weights of the dogs in group B were sig-
nificantly less in comparison with their initial ones or thergery c November 2008
Zhou et al General Thoracic SurgeryTABLE 1. Experimental results in esophageal tissues in dogs
Group (n) Stenosis index* Hydroxyproline (mg/mg)
Compliance
(cm H2O/mL)
A (6) 0.072 (0.050–0.099) 0.350 (0.309–0.463) 4.80 (4.38–4.93)
B (5) 0.400 (0.321–0.481)y 0.895 (0.785–1.131)y 0.60 (0.40–0.70)y
C (6) 0.053 (0.048–0.095) 0.429 (0.282–0.516) 3.30 (2.83–4.10)
D (6) 0.071 (0.047–0.093) 0.451 (0.281–0.535) 2.95 (2.85–3.38)
Values are presented as medians (25th-75th interquartile ranges). *Minimum intraluminal diameter (in millimeters)/maximum wall thickness (in millimeters). yP<.05 compared
with the remaining 3 groups.postexperimental weights in the remaining groups. The dogs
in groups C and D had no significant difference in weight be-
tween the pre-experimental and postexperimental periods
(Table E1).
Stenosis Index
The esophageal stenosis index in group B increased sig-
nificantly compared with that seen in groups A, C, and D.
There was no significant difference among the latter 3
groups (Table 1).
Histopothologic and Ultrastructural Findings
After removing the MES and opening the esophagus lon-
gitudinally, there was no ulceration or bleeding in the intra-
luminal membrane in groups C and D. Microscopic and
ultrastructural findings in group B featured a large amount
of collagen, which was arranged irregularly among fibro-
blast cells, and no inflammation was noted (Figures E2, A,
and Figure E3, A). The collagen bundles were thinner, and
their orientation tended toward regular and parallel patterns
in groups C and D compared with those in group B
(Figure E2, B, and Figure E3, B).
Hydroxyproline Levels
Hydroxyproline levels in esophageal tissue in group B
were more than twice those in groups A, C, and D. There
was no significant difference among hydroxyproline quanti-
ties in the latter 3 groups (Table 1).
Esophageal Compliance
Esophageal compliance in group B decreased signifi-
cantly in comparison with that in groups A, C, and D, but
there was an insignificant difference in esophageal compli-
ance in the latter 3 groups (Table 1).The Journal of Thoracic and CaEsophageal Biomechanics
In group B maximum load, elastic module, yield strength,
intensive strength, rupture intensity, and applied strength in-
creased while stretch rate at rupture and at definite force de-
creased significantly compared with those in groups A, C,
and D. There was no significant difference among esopha-
geal biomechanics in the latter 3 groups (Table E2). The
study revealed that elasticity improved and stiffness reduced
in esophageal tissues in groups C and D.
TGF-b1, Smad3, and Smad7 mRNA expression and
protein levels
In group B TGF-b1 and Smad3 mRNA expression and
protein levels were higher and Smad7 mRNA and protein
levels were significantly lower than those in groups A, C,
and D (Tables 2 and 3 and Figures E4 and E5). Their differ-
ences were insignificant among the latter 3 groups. Dogs
were taken in group B to compare the correlations among
the TGF-b1, Smad3, and Smad7 mRNA expression and pro-
tein levels. TGF-b1 mRNA and protein levels had a positive
correlation with Smad3 but a negative correlation with
Smad7 (Tables 2 and 3).
DISCUSSION
Current coverable metallic stents, the efficacy of which
has been well established in the treatment of malignant
esophageal stricture and fistula,8 are impossible to use to
prevent stricture formation after corrosive esophageal burns.
It is well known that scar tissue progressively contracts sev-
eral months after the start of the healing process after caustic
agent ingestion. Four to 6 months is required to keep the
esophageal stent in situ to prevent stricture formation.1,15
Fibrotic tissue, especially at the proximal and distal ends
of the stent, cause the stent removal to be difficult, evenG
T
STABLE 2. TGF-b1, Smad3, and Smad7 mRNA expression
Group (n) TGF-b1/b-actiny Smad3/b-actin Smad7/b-actin
A (6) 0.434 (0.352–0.461) 0.418 (0.304–0.554) 0.624 (0.603–0.647)
B (5) 1.326 (1.179–1.352)z 0.914 (0.903–1.271)z 0.269 (0.245–0.321)z
C (6) 0.461 (0.383–0.312)* 0.515 (0.458–0.578)* 0.834 (0.626–1.252)
D (6) 0.445 (0.349–0.512) 0.468 (0.347–0.500) 0.776 (0.631–1.132)
Values are presented as medians (25th-75th interquartile ranges). *P< .05 compared with the remaining groups. yP< .05, positive correlation with Smad3. zP< .05, negative
correlation with Smad7.rdiovascular Surgery c Volume 136, Number 5 1339
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STABLE 3. TGF-b1, Smad3, and Smad7 protein levels
Group (n) TGF-b1/group Ay Smad3/group A Smad7/group A
A (6) 1.000 (1.000–1.000) 1.000 (1.000–1.000) 1.000 (1.000–1.000)
B (5) 1.987 (1.894–2.068)z 2.717 (2.138–3.031)z 0.289 (0.267–0.371)z
C (6) 0.823 (0.650–1.053)* 1.049 (0.979–1.109)* 0.974 (0.961–1.040)
D (6) 0.934 (0.623–1.013) 0.948 (0.907–1.022) 0.988 (0.982–1.036)
Values are presented as medians (25th-75th interquartile ranges). *P< .05 compared with the remaining groups. yP< .05, positive correlation with Smad3. zP< .05, negative
correlation with Smad7.impossible, after several months of use. Most metal stents
cannot be removed without surgical intervention. Moreover,
long-term consequences of metal stent use can result in
esophageal restenosis and rare but life-threatening complica-
tions, such as perforation and severe bleeding.8,16 Although
some metal stents were extracted without surgical interven-
tion,9,10 in these cases they were only able to remove the
stents that had been in place for less than 1 month, even
less than 1 week. Even though Song and colleagues17 con-
structed a special modified hook, they could only withdraw
nitinol stents after 8 weeks of placement at best. Otherwise,
the current stents are made of silicone and have the draw-
back of being obstructed easily. Therefore we modified the
current covered expandable metal stent based on its patho-
physiology after insertion to be used to prevent stricture for-
mation after caustic esophageal burns.
The primary strategy for design of the MES is to prevent
fibrotic tissue ingrowth and remove it conveniently. The fea-
tures of the MES included the following. First, silicone coat-
ing of the inside and outside of the MES was thickened in an
attempt to keep it intact 4 months after placement to elimi-
nate hyperplastic tissue ingrowth through the mesh. Second,
coating of 1 cm beyond the upper metal section of the MES
was used to prevent tissue ingrowth at the proximal end of
the MES. Third, plastic valves attached to the MES’s lower
end were used to obviate fibrotic tissue ingrowth at the distal
end of the MES. Finally, the long nitinol string, which was
sheathed in a 10F catheter to forestall injury to the contigu-
ous esophageal tissue, was used to pull up the MES for stent
removal. In our study the MES was removed successfully
and conveniently after 4 months. The silcone coating was in-
tact, and there was no blood or esophageal tissue on the ex-
tracted MES. The results demonstrated that the MES had
met all the conditions in the primary design.
As for the timing of stent placement after caustic inges-
tion, Motaf18 prefers 9 weeks after the injury rather than
the early period. However, most authors3,4,19 stented the in-
jured esophagus during the first 3 weeks and had successful
results. We would like to insert the MES in the second week
after caustic injury. This is because intense acute inflamma-
tory reactions, including edema, cell necrosis, fatty saponifi-
cation, blood vessel thrombosis followed by bacterial
infiltration, and mucosal sloughing, developed within the
first week of lye contact. Furthermore, experimental animals
had anorexia at this time. Stenting might exacerbate the in-1340 The Journal of Thoracic and Cardiovascular Sujury and predispose the animal to esophageal perforation
at this time. One dog died of esophageal perforation after
stenting during the first postcaustic week in our preliminary
experiment. If the MESs were installed 3 weeks after the in-
jury or since then, the injured animals began to have symp-
tomatic strictures, and dilation can be required. During the
second week after the burn, although synthesis, deposition,
and remodeling of collagen became apparent, esophageal
stricture still had not formed.1 That is the reason why all
the MESs were installed during the second week of injury
in this study. MES placement was successful, with no
need for esophageal dilation in all 12 dogs.
Experimental and clinical evidence suggest that 4 factors,
including the obliteration of esophageal lumen by edema
and exuberant granulation tissue, adhesion between adjacent
ulcerated areas, contraction of the fibrous scar formed in the
esophageal wall, and destruction of the myenteric plexus, are
responsible for the development of stricture after caustic
esophageal injury.19 In the laboratory intraluminal splinting
with an inert material, such as Silastic, reduced the amount
of inflammation and granulation tissue and minimized scar-
ing. In addition, having the stent in place prevented the fu-
sion of mural ulcers and obliteration of the lumen by
granulation tissue during the remodeling period of the cica-
trized esophagus when it persisted for several months.4
MESs also performed a similar function. In this study
most of the dogs (4/5) in group B had early and variable mor-
tality before the experiment ended. This early mortality
might have created a form of lead time bias. However, the
esophageal pathophysiology in injured dogs was stricture
formation of more than 3 weeks in the wake of injury. The
first dog died 2 months after the injury. Even if all the
dogs had survived the experiment, esophageal stricture
would still be the main manifestation. Therefore group B
was reported, and comparative analysis was conducted.
Compared with dogs with untreated burns, the esophageal
stenosis index and hydroxyproline quantities decreased sig-
nificantly, the orientation of collagen tended toward a regular
and parallel pattern, and the esophageal compliance and
elasticity in biomechanics improved dramatically with
MES placement after caustic esophageal burns. These vari-
ables showed no significant changes after 2 months in the
wake of MES removal. MESs might decrease the synthesis
and deposition of the collagen and regulate its arrangement
to prevent stricture formation after corrosive injury in lightrgery c November 2008
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ical results in patients with advanced esophageal cancer, in
which a metal stent induces the fibrotic reaction.8 Injured
esophageal tissue and cancer cells might have different re-
sponses to the installed metal stent at the molecular level.
TGF-b is a central mediator of wound healing and scaring
processes throughout the body. The development of keloid
and hypertrophic scarring and pulmonary, renal, and hepatic
fibrosis are all involved with increased expression of TGF-
b1. This is primarily because of TGF-b1 promoting extracel-
lular matrix production while simultaneously suppressing
extracellular matrix proteolysis and breakdown.20 TGF-b in-
duces its type I and type II receptors to form heteromers in
which the type II receptor phosphorylates and activates the
type I receptor, which in turn activates cytoplasmic signaling
mediators known as Smads. Among the 8 Smads that have
been found in vertebrates, TGF-b/Smad3 might play a central
role in specific pathologic fibrosis.21 However, Smad7, a natu-
ral antagonist of TGF-b signaling, acts through Smad3 recep-
tor interactions and subsequent phosphorylation and by
recruiting E3 ubiquitin ligases called Smad ubiquitin regula-
tory factor Smurf1 and Smurf2 to the receptor complexes,
leading to the degradation of the latter.22 In this study, com-
pared with the dogs with untreated esophageal burns, the
dogs with MES treatment after injury had lower TGF-b and
Smad3 mRNA expression and protein levels and higher
Smad7 mRNA expression and protein levels. It is suggested
that TGF-b1, Smad3, and Smad7 might contribute to one of
the molecular mechanisms of MES preventing stricture forma-
tion after corrosive esophageal burns.
To our knowledge, the Alveolus stent (Alveolus, Inc) and
Polyflex plastic stents (Ru¨sch) are presently available and in
use successfully in benign disease. Both of them appear to be
easy to insert and simple to remove (requiring only flexible
endoscopy) and can be used to manage benign esophageal
disease. However, the data on benign esophageal strictures
have been mixed. Multicenter prospective studies are needed
to evaluate the late complication rate and long-term effective-
ness.23 Furthermore, stent migration might be their Achilles’
heel. Baron and colleagues24 reported that 7 of 8 Alveolus
esophageal stent displacements occurred in a porcine model.
Siddiqui and coworkers25 showed that Polyflex silicone
stents migrated into the stomach in 60% patients with esoph-
ageal stenosis, and there was no proximal migration. Other
authors26 also concluded that stent migration was the most
common long-term complication. Our stent has a piece of ni-
tinol string of 0.5 mm in diameter and 50 cm in length trans-
fixed to the upper metal circumference of the MES to keep it
in place. Use of a string that penetrated the pharynx to retrieve
the stent in human subjects might be possible because the
string was sheathed in a 12F catheter that had been used in
patients with corrosive esophageal burns in our depart-
ment.15 Moreover, plastic valves were attached to the lower
end of the MES to decrease gastroesophageal reflux.The Journal of Thoracic and CIn conclusion, an animal model of esophageal stricture af-
ter corrosive esophageal burns with NaOH introduced in this
study is an easily performed procedure. MESs can be re-
moved successfully and conveniently after 4 months of
placement and prevent esophageal stricture formation after
caustic injury in mongrel dogs. MESs might be a promising
stent in preventing the development of stricture in patients
after serious corrosive esophageal burns and managing other
benign stenoses after the lengths of MES and its string are
adjusted in light of the esophageal lesion.
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SFIGURE E2. Light microscopic studies on the esophageal tissue in dogs. (Hematoxylin and eosin stain, original magnification 2003.) A, Fibroblast cells
with a large amount of irregularly arranged collagen deposition in group B. B, Less fibroblast cells and collagen bundles with regular orientation in group D
compared with those in group B.1342.e2 The Journal of Thoracic and Cardiovascular Surgery c November 2008
Zhou et al General Thoracic SurgeryFIGURE E3. Transmission electron microscopic studies of the esophageal tissue in dogs. (Original magnification 42003.) A, Irregularly arranged collagen
bundles in group B. B, Thinner collagen bundles with regular orientation in group D compared with those in group B.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 5 1342.e3
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tissue in dogs. TGF-b1 and Smad3 levels decreased and Smad7 levels increased in the stented group compared with those in the untreated group. b-actin
was used as the control gene.1342.e4 The Journal of Thoracic and Cardiovascular Surgery c November 2008
Zhou et al General Thoracic SurgeryFIGURE E5. Western blot showing chemiluminescent film of TGF-b1, Smad3, and Smad7 protein in esophageal tissue in dogs. TGF-b1 and Smad3 levels
decreased and Smad7 levels increased in the stented group compared with those in the untreated group.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 5 1342.e5
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STABLE E1. Comparison of pre-experimental and post-experimental canine weight
Before the experiment After the experiment
Group n Weight (kg) n Weight (kg)
A 6 12.8 (11.4–15.1) 6 13.0 (12.3–14.6)
B 6 13.5 (12.9–14.6) 5 9.5 (8.8–10.0)*y
C 6 13.3 (12.4–14.8) 6 13.5 (12.4–14.3)
D 6 13.5 (12.9–14.3) 6 13.0 (12.5–14.5)
*P< .05 compared with initial weight. yP<0.05 compared with postexperimental weight in the remaining 3 groups.1342.e6 The Journal of Thoracic and Cardiovascular Surgery c November 2008
Zhou et al General Thoracic SurgeryTABLE E2. Esophageal biomechanics in dogs
Group (n)
Biomechanics A (6) B (5) C (6) D (5)
Maximum load 27.4 (19.8–32.1) 65.4 (52.0–80.1)* 23.4 (19.6–29.8) 25.7 (19.8–32.9)
Elastic module 1.7 (0.7–2.7) 4.7 (3.4–6.1)* 1.4 (1.1–2.4) 1.2 (0.6–1.6)
Yield strength 1.1 (0.3–2.2) 3.3 (3.0–4.5)* 1.1 (0.8–2.0) 0.89 (0.4–1.0)
Intensive strength 1.1 (0.4–1.5) 4.6 (3.6–5.0)* 1.7 (0.9–2.5) 1.2 (0.8–1.9)
Rupture intensity 0.8 (0.3–1.1) 3.0 (1.7–3.5)* 0.7 (0.6–1.4) 0.7 (0.2–1.2)
Applied strength 0.2 (0.1–0.3) 1.0 (0.9–1.3)* 0.3 (0.1–0.7) 0.4 (0.3–0.5)
Stretch rate
at rupture
107.8 (95.8–120.1) 56.3 (43.7–63.1)* 139.6 (114.7–173.6) 119.7 (81.3–143.2)
Stretch rate
at definite force
15.3 (11.6–20.5) 7.3 (3.9–8.7)* 21.2 (15.3–26.4) 26.2 (14.4–29.2)
*P< .05 compared with the remaining 3 groups.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 5 1342.e7
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